Vaxxinact H5

Unknown🇪🇺 European Union

EMA Page

Authorised Date: N/A
Approval ID: acddb90920bdee22
Products: 1 listed
Opinion Adopted: N/A

Overview Summary

Up\-to\-date information on this veterinary medicinal product is available on the [Veterinary Medicines Information website.](https://medicines.health.europa.eu/veterinary/en/search-medicines?keys=Vaxxinact-H5)

Therapeutic & Classification

Therapeutic Indication

N/A

Therapeutic Area (MeSH)

N/A

ATC Code

N/A

ATC Item

N/A

Pharmacotherapeutic Group

N/A

Active Substances

Active Substance (Summary)

Avian influenza virus, subtype H5, haemagglutinin (recombinant)

INN / Common Names

Avian influenza virus, subtype H5, haemagglutinin (recombinant)

Active Substance Details

Active substance details are not yet available.

Quick Info

Approval IDacddb90920bdee22

Product NumberN/A

StatusAuthorised

Authorised DateN/A

Opinion AdoptedN/A

Revision #N/A

Names & Aliases

EMA Name

Vaxxinact H5

Medicine Name

Vaxxinact H5

Aliases

N/A

Regulatory Flags

Orphan medicineUnknown

Generic medicineUnknown

BiosimilarUnknown

Conditional approvalUnknown

Exceptional circumstancesUnknown

Accelerated assessmentUnknown

Additional monitoringUnknown

Advanced therapyUnknown

Source Links

EMA Source

No risk management plan link.

Back to EMA Approvals